Come up with a name for your new list and we'll add to it:
Cincera Therapeutics raised a round of funding on February 19, 2018. Investors include
Medical Research Commercialisation Fund.
Cincera Therapeutics develops novel drugs aiming to transform the treatment of inflammatory and fibrotic indications associated with metabolic diseases such as type 2 diabetes and other indications.…